中西医结合治疗慢性肺源性心脏病的临床疗效观察

目的:探讨中西医结合治疗慢性肺源性心脏病的临床治疗效果,评价其临床应用价值.方法:将该院130例慢性肺源性心脏病患者,按接受治疗先后顺序随机分为对照组和治疗组,每组各65例.对照组采用西医常规治疗,治疗组在对照组治疗的基础上加用中药配方,水煎,1剂/d,早晚各1次,治疗以4周为1个疗程,两组疗程完成后,对患者的肺功能相关指标及疗效进行分析比较.结果:治疗组与对照组患者治疗前后1秒率( FEV1/FVC),最高呼气流速(PEF),最大通气量(MVV)等肺功能指标显著改善,治疗后治疗组患者肺功能指标明显优于对照组,差异均具有统计学意义(P＜0.05)；治疗组患者治疗有效率为93.85％,显著高于对照组(有效率78.46％),差异具有统计学意义(P＜0.05).结论:中西医结合治疗慢性肺源性心脏病能显著提高临床治疗效果,对提高患者生活质量及改善患者预后有重要的意义.

Clinical Observation on Curative Effect of Combination of Traditional Chinese Medicine with Western Medicine on Pulmonary Heart Disease

Objective:To explore clinical efficacy of the combination of traditional Chinese medicine(TCM) and western medicine treatment of chronic pulmonary heart disease,and to evaluate its clinical value.Method:One hundred and thirty patients with chronic pulmonary heart disease in the hospital were randomized divided into the control group and the treatment group,65 cases in each group.Conventional western medicine treatment was taken in the control group.The treatment group was given TCM medicine based on the treatment of the control group,after treatment,the two groups’ patient’s indicators of lung function and clinical efficacy were analyzed and compared.Result:Indicators of lung function,such as forced expiratory volume/forced vital capacity(FEV1/FVC),Peak expiratory flow(PEF),maximum ventilatory volume(MVV) in the treatment group and control group were improved significantly,and indicators of lung function of patients in treatment group were better than that in the control group after treatment,the differences were statistically significant(P<0.05).Efficiency of treatment of patients in treatment group was 93.85%,and was significantly higher than 78.46% in the control group,the difference was statistically significant(P<0.05).Conclusion:The combination of TCM with Western medicine on pulmonary heart disease can significantly improve curative clinical effect,it has important implications in improving the quality of life and the prognosis of patients.